156 related articles for article (PubMed ID: 36209259)
61. Comparison of Liver Graft Regeneration Between ABO-Compatible and ABO-Incompatible Living Donor Liver Transplantation: A Propensity Score Matching Analysis.
Chae MS; Lee N; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
Ann Transplant; 2018 Jul; 23():507-519. PubMed ID: 30050031
[TBL] [Abstract][Full Text] [Related]
62. [ABO INCOMPATIBLE KIDNEY TRANSPLANTATION].
Eisner S; Orlin J; Nesher E; Mazhybovsky V; Gurevich M; Michowiz R; Rahamimov R; Mor E
Harefuah; 2017 Apr; 156(4):237-241. PubMed ID: 28551928
[TBL] [Abstract][Full Text] [Related]
63. Impact of the Pediatric ABO Policy Change on Listings, Transplants, and Outcomes for Children Younger Than 2 Years Listed for Heart Transplantation in the United States.
Amdani S; Deshpande SR; Liu W; Urschel S
J Card Fail; 2024 Mar; 30(3):476-485. PubMed ID: 37328049
[TBL] [Abstract][Full Text] [Related]
64. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction.
Lehnhardt AM; Strecker M; Eiermann T; Marget M; Thaiss F; Nashan B; Koch M
Clin Transplant; 2015 Apr; 29(4):359-64. PubMed ID: 25627801
[TBL] [Abstract][Full Text] [Related]
65. The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation.
Genberg H; Kumlien G; Wennberg L; Tyden G
Nephrol Dial Transplant; 2011 Jul; 26(7):2394-400. PubMed ID: 21558429
[TBL] [Abstract][Full Text] [Related]
66. Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression.
Flint SM; Walker RG; Hogan C; Haeusler MN; Robertson A; Francis DM; Millar R; Finlay M; Landgren A; Cohney SJ
Am J Transplant; 2011 May; 11(5):1016-24. PubMed ID: 21449947
[TBL] [Abstract][Full Text] [Related]
67. Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study.
Ko EJ; Yu JH; Yang CW; Chung BH;
Transpl Int; 2017 Dec; 30(12):1215-1225. PubMed ID: 28493630
[TBL] [Abstract][Full Text] [Related]
68. Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation.
Barnett AN; Manook M; Nagendran M; Kenchayikoppad S; Vaughan R; Dorling A; Hadjianastassiou VG; Mamode N
Transpl Int; 2014 Feb; 27(2):187-96. PubMed ID: 24188566
[TBL] [Abstract][Full Text] [Related]
69. Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption - a retrospective study.
Speer C; Kälble F; Nusshag C; Pego da Silva L; Schaier M; Becker LE; Klein K; Sommerer C; Beimler J; Leo A; Waldherr R; Mehrabi A; Süsal C; Zeier M; Morath C
Transpl Int; 2019 Dec; 32(12):1286-1296. PubMed ID: 31322786
[TBL] [Abstract][Full Text] [Related]
70. Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation.
Ishida H; Kondo T; Shimizu T; Nozaki T; Tanabe K
Transpl Int; 2015 Mar; 28(3):286-96. PubMed ID: 25363583
[TBL] [Abstract][Full Text] [Related]
71. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
[TBL] [Abstract][Full Text] [Related]
72. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
[TBL] [Abstract][Full Text] [Related]
73. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
[TBL] [Abstract][Full Text] [Related]
74. Postoperative Events in Incompatible Living Donor Kidney Transplant Recipients Undergoing Prior Desensitization.
García-Sobrino R; Vazquez-Martul D; Fernández-Rivera C; López-Muñiz A; Balboa-Barreiro V; Suárez-Pascual G; Díaz-Reixa JLP; Chantada-Abal V
Transplant Proc; 2023 Sep; 55(7):1575-1580. PubMed ID: 37455168
[TBL] [Abstract][Full Text] [Related]
75. Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India.
Ray DS; Thukral S
Transplant Proc; 2016 Oct; 48(8):2622-2628. PubMed ID: 27788792
[TBL] [Abstract][Full Text] [Related]
76. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
[TBL] [Abstract][Full Text] [Related]
77. Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis.
Lo P; Sharma A; Craig JC; Wyburn K; Lim W; Chapman JR; Palmer SC; Strippoli GF; Wong G
Transplantation; 2016 Apr; 100(4):933-42. PubMed ID: 26425876
[TBL] [Abstract][Full Text] [Related]
78. Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.
Yamamoto T; Kawaguchi T; Watarai Y; Tujita M; Hiramitsu T; Nanmoku K; Goto N; Katayama A; Kobayashi T; Uchida K
Transplant Proc; 2012 Jan; 44(1):210-3. PubMed ID: 22310616
[TBL] [Abstract][Full Text] [Related]
79. ABO-incompatible transplantation without conventional induction immunosuppression (IL-2RB or depleting agents).
Hafeeq B; Aziz F; Narayanan S; Aboobacker IN; Gopinathan JC; Narayanan R; Binu JJ; Uvais NA
Saudi J Kidney Dis Transpl; 2020; 31(3):572-581. PubMed ID: 32655043
[TBL] [Abstract][Full Text] [Related]
80. Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study.
Kwon H; Kim JY; Kim DH; Ko Y; Choi JY; Shin S; Jung JH; Kim YH; Han DJ;
Sci Rep; 2019 Dec; 9(1):18229. PubMed ID: 31796812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
